Direxion Shares ETF Trust Daily Pharmaceutical & Medical Bull 3X Shares logo

Direxion Shares ETF Trust Daily Pharmaceutical & Medical Bull 3X Shares (PILL)

Market Closed
10 Aug, 20:00
ARCA ARCA
$
20. 61
-0.15
-0.7225%
$
42.95M Market Cap
0.09% Div Yield
38,521 Volume
$ 20.76
Previous Close
Add Transaction
Day Range
20.2 20.91
Year Range
6.1 21.34
Want to track PILL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

PILL closed today lower at $20.61, a decrease of -0.7225% from yesterday's close, completing a monthly increase of 13.1175% or $2.39. Over the past 12 months, PILL stock gained 63.1829%.
PILL pays dividends to its shareholders, with the most recent payment made on Jun 30, 2026. The next estimated payment will be in In 1 month on Sep 30, 2026 for a total of $0.01517.
The stock of the company had never split.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on ARCA (USD).

PILL Chart

Direxion Shares ETF Trust Daily Pharmaceutical & Medical Bull 3X Shares (PILL) FAQ

What is the stock price today?

The current price is $20.61.

On which exchange is it traded?

Direxion Shares ETF Trust Daily Pharmaceutical & Medical Bull 3X Shares is listed on ARCA.

What is its stock symbol?

The ticker symbol is PILL.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.09%.

What is its market cap?

As of today, the market cap is 42.95M.

Has Direxion Shares ETF Trust Daily Pharmaceutical & Medical Bull 3X Shares ever had a stock split?

No, there has never been a stock split.

Direxion Shares ETF Trust Daily Pharmaceutical & Medical Bull 3X Shares Profile

ARCA Exchange
US Country

Overview

The described company operates as an investment fund focused on providing its investors with leveraged exposure to the pharmaceutical sector. By committing at least 80% of its net assets into financial instruments, the fund aims to offer 3X daily leveraged exposure to its underlying index. This index is a modified equal-weighted gauge that tracks the performance of companies within the S&P Total Market Index that fall under the GICS pharmaceuticals sub-industry classification. Characterized as a non-diversified fund, it concentrates its investments more narrowly than diversified counterparts, aiming to capitalize on the growth potential within the pharmaceutical industry.

Products and Services

Key offerings of the fund include:

  • Leveraged Pharmaceutical Exposure

    The primary service offered by the fund is its investment vehicle designed to provide investors with 3X daily leveraged exposure to the pharmaceutical sector. This product targets those looking to amplify their investment outcomes based on the performance of pharmaceutical stocks within the S&P Total Market Index. It’s suitable for investors seeking aggressive growth strategies and who understand the risks associated with leveraged investments.

  • Pharmaceuticals Sub-Industry Index Focus

    Investment focuses on a modified equal-weighted index that measures the performance of the S&P Total Market Index stocks classified in the GICS pharmaceuticals sub-industry. This strategy offers investors a specialized exposure to pharmaceutical companies, aiming for growth through concentrated investment in this healthcare segment. The fund's strategy is built on the premise that the pharmaceutical industry offers unique growth opportunities, which can be capitalized on through a focused investment approach.

Contact Information

Address: 1301 Avenue of the Americas, 28th Floor
Phone: 1-866-476-7523